AEON · AEON Biopharma, Inc.
$0.31
+0.02 (+5.31%)
At close · Aug 28
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, management has concluded that substantial doubt about our ability to continue as a going concern exists as conditions and events, considered in the aggregate, indicate that it is probable that we will be unable to meet our obligations as they become due within one year after the date that the financial statements included in this Report are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$12.55M
Shares
49.88M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-20 | 106,239 | 886,745 | 992,984 | 57.0% |
| 2026-07-13 | 6,389,411 | 34,979,898 | 41,369,309 | 62.3% |
| 2026-07-06 | 30,924 | 341,870 | 372,794 | 57.3% |
| 2026-06-29 | 2,597 | 41,850 | 44,447 | 58.8% |
| 2026-06-22 | 7,816 | 80,295 | 88,111 | 61.1% |
| 2026-06-15 | 2,832 | 73,761 | 76,593 | 51.2% |
| 2026-06-08 | 4,793 | 139,546 | 144,339 | 64.4% |
| 2026-06-01 | 2,435 | 62,483 | 64,918 | 71.7% |
| 2026-05-25 | 2,395 | 99,054 | 101,449 | 64.7% |
| 2026-05-18 | 32,215 | 269,791 | 302,006 | 61.1% |
| 2026-05-11 | 8,420 | 272,246 | 280,666 | 71.8% |
| 2026-05-04 | 36,761 | 153,762 | 190,523 | 63.3% |
| 2026-04-27 | 29,735 | 217,126 | 246,861 | 58.3% |
| 2026-04-20 | 18,497 | 166,486 | 184,983 | 40.2% |
| 2026-04-13 | 12,073 | 305,704 | 317,777 | 21.5% |
| 2026-04-06 | 10,127 | 206,148 | 216,275 | 55.7% |
| 2026-03-30 | 9,215 | 204,533 | 213,748 | 54.8% |
| 2026-03-23 | 23,388 | 376,980 | 400,368 | 60.9% |
| 2026-03-16 | 9,318 | 96,454 | 105,772 | 61.7% |
| 2026-03-09 | 16,282 | 213,452 | 229,734 | 59.3% |
| 2026-03-02 | 8,544 | 146,485 | 155,029 | 59.3% |
| 2026-02-23 | 23,624 | 309,285 | 332,909 | 46.7% |
| 2026-02-16 | 9,487 | 135,109 | 144,596 | 59.8% |
| 2026-02-09 | 20,745 | 236,096 | 256,841 | 64.6% |
| 2026-02-02 | 26,626 | 292,405 | 319,031 | 62.6% |
| 2026-01-26 | 17,689 | 276,338 | 294,027 | 65.5% |
| 2026-01-19 | 69,909 | 1,037,375 | 1,107,284 | 36.6% |
| 2026-01-12 | 32,031 | 541,767 | 573,798 | 67.3% |
| 2026-01-05 | 44,342 | 561,504 | 605,846 | 57.1% |
| 2025-12-29 | 74,679 | 553,546 | 628,225 | 66.4% |
| 2025-12-22 | 30,040 | 344,825 | 374,865 | 59.5% |
| 2025-12-15 | 57,529 | 800,679 | 858,208 | 67.3% |
| 2025-12-08 | 37,196 | 471,254 | 508,450 | 60.7% |
| 2025-12-01 | 15,680 | 272,928 | 288,608 | 49.2% |
| 2025-11-24 | 32,835 | 162,591 | 195,426 | 61.8% |
| 2025-11-17 | 58,408 | 1,252,607 | 1,311,015 | 56.5% |
| 2025-11-10 | 18,083 | 760,688 | 778,771 | 52.6% |
| 2025-11-03 | 35,980 | 576,372 | 612,352 | 66.3% |
| 2025-10-27 | 10,512 | 431,603 | 442,115 | 60.9% |
| 2025-10-20 | 31,448 | 952,548 | 983,996 | 68.9% |
| 2025-10-13 | 133,623 | 1,972,754 | 2,106,377 | 65.2% |
| 2025-10-06 | 84,498 | 1,788,645 | 1,873,143 | 66.3% |
| 2025-09-29 | 25,550 | 350,776 | 376,326 | 72.6% |
| 2025-09-22 | 24,096 | 559,343 | 583,439 | 69.4% |
| 2025-09-15 | 6,555 | 204,135 | 210,690 | 63.9% |
| 2025-09-08 | 25,341 | 271,450 | 296,791 | 65.9% |
| 2025-09-01 | 20,718 | 113,419 | 134,137 | 45.8% |
Showing 1–47 of 47 weeks
Key facts
CIK
1837607
CUSIP
00791X209
13F (30d)
19 filings
19 filers
Visit website
Investor relations